HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epidemiological mechanisms of genetic resistance to kuru.

Abstract
Transmissible spongiform encephalopathies (TSEs), such as kuru, are invariably fatal neurodegenerative conditions caused by a malformation of the prion protein. Heterozygosity of codon 129 of the prion protein gene has been associated with increased host resistance to TSEs, although the mechanism by which this resistance is achieved has not been determined. To evaluate the epidemiological mechanism of human resistance to kuru, we developed a model that combines the dynamics of kuru transmission and the population genetics of human resistance. We fitted our model to kuru data from the epidemic that occurred in Papua New Guinea over the last hundred years. To elucidate the epidemiological mechanism of human resistance, we estimated the incubation period and transmission rate of kuru for codon 129 heterozygotes and homozygotes using kuru incidence data and human genotype frequency data from 1957 to 2004. Our results indicate that human resistance arises from a combination of both a longer incubation period and reduced susceptibility to infection. This work provides evidence for balancing selection acting on a human population and the mechanistic basis for the heterozygote resistance to kuru.
AuthorsKatherine E Atkins, Jeffrey P Townsend, Jan Medlock, Alison P Galvani
JournalJournal of the Royal Society, Interface (J R Soc Interface) Vol. 10 Issue 85 Pg. 20130331 (Aug 06 2013) ISSN: 1742-5662 [Electronic] England
PMID23740487 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Codon
  • Prions
Topics
  • Codon (genetics)
  • Disease Resistance (genetics)
  • Female
  • Heterozygote
  • Homozygote
  • Humans
  • Kuru (epidemiology, genetics)
  • Male
  • Models, Genetic
  • Papua New Guinea (epidemiology)
  • Prions (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: